Pretreatment of MCF-7 breast cancer cells with an inhibitor of NF-κB prior to curcumin treatment suggested that curcumin-mediated alterations in c-MYC, ODC, SSAT, and PAOX protein levels occurred in part through this signaling pathway [84]. The gene discussed is NFKB1; the disease is breast carcinoma.